Microbot Medical Stock Shares Owned By Insiders
| CY9D Stock | EUR 1.71 0.11 6.04% |
Microbot Medical fundamentals help investors to digest information that contributes to Microbot Medical's financial success or failures. It also enables traders to predict the movement of Microbot Stock. The fundamental analysis module provides a way to measure Microbot Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Microbot Medical stock.
Microbot |
Microbot Medical Company Shares Owned By Insiders Analysis
Microbot Medical's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Microbot Medical Shares Owned By Insiders | 3.07 % |
Most of Microbot Medical's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Microbot Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 3.067% of Microbot Medical are shares owned by insiders. This is 79.8% lower than that of the Healthcare sector and 80.46% lower than that of the Medical Instruments & Supplies industry. The shares owned by insiders for all Germany stocks is 69.6% higher than that of the company.
Microbot Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Microbot Medical's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Microbot Medical could also be used in its relative valuation, which is a method of valuing Microbot Medical by comparing valuation metrics of similar companies.Microbot Medical is currently under evaluation in shares owned by insiders category among its peers.
Microbot Fundamentals
| Return On Equity | -1.2 | |||
| Return On Asset | -0.65 | |||
| Current Valuation | 25.69 M | |||
| Shares Outstanding | 7.89 M | |||
| Shares Owned By Insiders | 3.07 % | |||
| Shares Owned By Institutions | 29.65 % | |||
| Price To Book | 5.90 X | |||
| EBITDA | (11.28 M) | |||
| Net Income | (11.31 M) | |||
| Cash And Equivalents | 20.62 M | |||
| Cash Per Share | 2.90 X | |||
| Total Debt | 708 K | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 17.41 X | |||
| Book Value Per Share | 0.78 X | |||
| Cash Flow From Operations | (9.35 M) | |||
| Earnings Per Share | (1.76) X | |||
| Number Of Employees | 20 | |||
| Beta | 3.26 | |||
| Market Capitalization | 20.07 M | |||
| Total Asset | 16.77 M | |||
| Z Score | 16.8 | |||
| Net Asset | 16.77 M |
About Microbot Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Microbot Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Microbot Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Microbot Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Additional Information and Resources on Investing in Microbot Stock
When determining whether Microbot Medical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Microbot Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Microbot Medical Stock. Highlighted below are key reports to facilitate an investment decision about Microbot Medical Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more detail on how to invest in Microbot Stock please use our How to Invest in Microbot Medical guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.